Saffie Sandford is a 6-year-old girl who has experienced a dramatic improvement in her quality of life after undergoing a cutting-edge medical procedure.
Diagnosed with Leber congenital amaurosis at Great Ormond Street Hospital, the patient had a mutation that prevented her eyes from producing a protein essential for vision.
After receiving the gene therapy known as Luxturna in 2025, the girl has been able to perceive her surroundings in low-light conditions, allowing her to perform daily activities that were previously impossible. Specialists at University College London emphasize that intervening in the early stages of visual development is key to strengthening neural pathways.
